Browsing by Subject "Cholesterol--Pathophysiology"
Now showing items 1-1 of 1
-
PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
(Brac University, 2023-02)One of the largest global causes of morbidity and mortality is cardiovascular disease (CVD). Elevated low-density lipoprotein (LDL) levels and adverse cardiovascular outcomes are linked to increased levels of the proprotein ...